Viewing Study NCT01589718


Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2026-01-28 @ 5:12 PM
Study NCT ID: NCT01589718
Status: WITHDRAWN
Last Update Posted: 2014-03-05
First Post: 2012-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
Sponsor: Greater Houston Retina Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Proliferative Diabetic Retinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Proliferative Diabetic Retinopathy View
None Tractional Retinal Detachment View
None Vitreous Hemorrhage View